CDK 4/6 Inhibitors in Breast Cancer: Current Controversies and Future Directions.
Spring, Laura M
CDK 4/6 Inhibitors in Breast Cancer: Current Controversies and Future Directions. [electronic resource] - Current oncology reports 02 2019 - 25 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review
1534-6269
10.1007/s11912-019-0769-3 doi
Antineoplastic Agents--therapeutic use
Breast Neoplasms--drug therapy
Cyclin-Dependent Kinase 4--antagonists & inhibitors
Cyclin-Dependent Kinase 6--antagonists & inhibitors
Drug Resistance, Neoplasm
Female
Humans
Protein Kinase Inhibitors--therapeutic use
CDK 4/6 Inhibitors in Breast Cancer: Current Controversies and Future Directions. [electronic resource] - Current oncology reports 02 2019 - 25 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review
1534-6269
10.1007/s11912-019-0769-3 doi
Antineoplastic Agents--therapeutic use
Breast Neoplasms--drug therapy
Cyclin-Dependent Kinase 4--antagonists & inhibitors
Cyclin-Dependent Kinase 6--antagonists & inhibitors
Drug Resistance, Neoplasm
Female
Humans
Protein Kinase Inhibitors--therapeutic use